This renewal application seeks continuing support for the """"""""Microenvironmental Influences in Cancer"""""""" Training Program (MICTP) at Vanderbilt University. Over the past 24 years and continuing with the 5-year period preceding this competitive renewal, we have been remarkably successful in recruiting and training excellent students and postdoctoral fellows, particularly those from groups underrepresented in science. Overall, the MIC training program encompasses a group of 26 faculty members from both the Vanderbilt University School of Medicine and the Meharry Medical College. The training program is conducted within a vibrant academic environment and is supported by close interactions with the Vanderbilt-lngram Comprehensive Cancer Center, the Vanderbilt Department of Cancer Biology, and the Vanderbilt-Meharry Alliance Program. In addition to departmental and preceptor-specific laboratory instruction, each trainee receives cancer-related training in the form of two courses focused on cancer biology, a grant workshop, an annual Tumor-Host Interaction Program retreat, and a """"""""Clinical Experience"""""""". Trainees within the program are actively mentored by both faculty members and through """"""""paired peer mentoring"""""""" by former student and postdoctoral trainees. Furthermore, predoctoral students are supported by an Interdisciplinary Graduate Program and an independent graduate program in Cancer Biology. Postdoctoral trainees are supported by an institutional Office of Postdoctoral Affairs, which provides both financial and academic support as well as career development advice and opportunities. Significant institutional investment in training programs, core facilities, state-of the-art laboratories and equipment further enhances trainee development. Training in this critical area of cancer research is necessary to build the workforce required to understand the complexities of the microenvironmental influence on cancer development and progression, and to translate this information into more effective and less toxic approaches to the treatment and prevention of cancer. Furthermore, training in tumor microenvironment will prepare our students and postdoctoral fellows to solve the major unsolved or neglected problems, """"""""the provocative questions"""""""", in oncology.
One of the rapidly developing frontiers in cancer research is the tumor microenvironment. Training in this critical area of cancer research is necessary to build the workforce required to understand the complexities of the microenvironmental influence on cancer development and progression, and to translate this information into more effective and less toxic approaches to the treatment and prevention of cancer.
|Childress, Merrida A; Himmelberg, Stephen M; Chen, Huiqin et al. (2018) ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties. Mol Cancer Res 16:1724-1736|
|Fröse, Julia; Chen, Michelle B; Hebron, Katie E et al. (2018) Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling. Cell Rep 24:962-972|
|Doxie, Deon B; Greenplate, Allison R; Gandelman, Jocelyn S et al. (2018) BRAF and MEK inhibitor therapy eliminates Nestin-expressing melanoma cells in human tumors. Pigment Cell Melanoma Res 31:708-719|
|Almodovar, Karinna; Iams, Wade T; Meador, Catherine B et al. (2018) Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse. J Thorac Oncol 13:112-123|
|Hebron, Katie E; Li, Elizabeth Y; Arnold Egloff, Shanna A et al. (2018) Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis. Sci Rep 8:3208|
|Short, Sarah P; Kondo, Jumpei; Smalley-Freed, Whitney G et al. (2017) p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia. J Clin Invest 127:4462-4476|
|Kim, L C; Cook, R S; Chen, J (2017) mTORC1 and mTORC2 in cancer and the tumor microenvironment. Oncogene 36:2191-2201|
|Udyavar, Akshata R; Wooten, David J; Hoeksema, Megan et al. (2017) Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity. Cancer Res 77:1063-1074|
|Enyindah-Asonye, Gospel; Li, Yan; Ruth, Jeffrey H et al. (2017) CD318 is a ligand for CD6. Proc Natl Acad Sci U S A 114:E6912-E6921|
|Edwards, Deanna N; Ngwa, Verra M; Wang, Shan et al. (2017) The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. Sci Signal 10:|
Showing the most recent 10 out of 242 publications